Comments on “Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)”

Carlo Cattrini; Carlo Messina; Alessia Mennitto; Massimo Di Maio; Alessandra Gennari; David Olmos

doi:10.1002/ijc.34246

Comments on “Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)”

Carlo Cattrini
, Carlo Messina
, Alessia Mennitto
, Massimo Di Maio
, Alessandra Gennari
, David Olmos

Department of Translational Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	2291-2292
Number of pages	2
Journal	International Journal of Cancer
Volume	151
Issue number	12
DOIs	https://doi.org/10.1002/ijc.34246
Publication status	Published - 15 Dec 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1002/ijc.34246

Cite this

@article{47537b91b4664b1bada9cbe7a61ab58d,

title = "Comments on “Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)”",

author = "Carlo Cattrini and Carlo Messina and Alessia Mennitto and \{Di Maio\}, Massimo and Alessandra Gennari and David Olmos",

year = "2022",

month = dec,

day = "15",

doi = "10.1002/ijc.34246",

language = "English",

volume = "151",

pages = "2291--2292",

journal = "International Journal of Cancer",

issn = "0020-7136",

publisher = "John Wiley and Sons Inc.",

number = "12",

}

Comments on “Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)”. / Cattrini, Carlo; Messina, Carlo; Mennitto, Alessia et al.
In: International Journal of Cancer, Vol. 151, No. 12, 15.12.2022, p. 2291-2292.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Comments on “Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy

T2 - 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)”

AU - Cattrini, Carlo

AU - Messina, Carlo

AU - Mennitto, Alessia

AU - Di Maio, Massimo

AU - Gennari, Alessandra

AU - Olmos, David

PY - 2022/12/15

Y1 - 2022/12/15

UR - https://www.scopus.com/pages/publications/85137349843

U2 - 10.1002/ijc.34246

DO - 10.1002/ijc.34246

M3 - Letter

SN - 0020-7136

VL - 151

SP - 2291

EP - 2292

JO - International Journal of Cancer

JF - International Journal of Cancer

IS - 12

ER -

Comments on “Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)”

UN SDGs

Access to Document

Other files and links

Cite this